Skip to main content
Clinical Trials/ITMCTR1900002640
ITMCTR1900002640
Not yet recruiting
未知

A multicenter prospective clinical study for the treatment of spleen and kidney insufficiency metrorrhagia and metrostaxis with Lingnan Hemostatic Prescription Erren Decoction

The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Sponsor
The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Between the ages of 13 and 55 years.
  • 2\. (1\) suddenly a lot of violence under the vaginal bleeding; (2\) blood dripping more than 14 days (in line with one of them).
  • 3\. (1\) dark red or light red; (2\) by thin (accord with one of them).
  • 4\. (1\) weak waist and knees, chills and cold limbs, insomnia, tinnitus, and loss of libido; (2\) loose stool, fatigue, poor diet, abnormal complexion (yellow or white) (at least in line with 1, 2 in each).
  • 5\. Tongue veins: the tongue is light and dark, with thin white coating and heavy and fine veins.
  • 6\. The subject voluntarily participates in the study and has signed the informed consent.

Exclusion Criteria

  • 1\. Vaginal bleeding caused by pregnancy.
  • 2\. Organic lesions, such as genital malignant tumor, uterine fibroids, adenomyosis and other abnormal uterine bleeding.
  • 3\. Abnormal uterine bleeding caused by reproductive tract infection.
  • 4\. Bleeding of vulva, vagina and cervix.
  • 5\. Abnormal uterine bleeding caused by cardiovascular diseases, liver diseases, blood system diseases, etc.
  • 6\. Hemoglobin less than 90g/L.

Outcomes

Primary Outcomes

Not specified

Similar Trials